Related Articles
Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells
Histone deacetylase inhibitors: Apoptotic effects and clinical implications (Review)
Deficient histone acetylation and excessive deacetylase activity as epigenomic marks of prostate cancer cells
HAT/HDAC: The epigenetic regulators of inflammatory gene expression (Review)
Histone H4 acetylation and histone deacetylase 1 expression in esophageal squamous cell carcinoma